Software Engineer I, Veeva Quality at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Entry Level & New Grad, Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Pharmaceutical, BiotechnologyIndustries

Requirements

University degree and 4-5 years of experience
Thorough knowledge of principles and concepts of a discipline and developed knowledge of related disciplines
Experience in implementing/supporting SaaS (Software as a Service) solutions
Experience in automated testing tools
Experience in life science industry with Quality domain knowledge
Experience in GMP (Good Manufacturing Practice) practices
Strong commitment to a career in technology with a passion for healthcare
Ability to understand business needs and deliver best user experience and adoption
Ability to collaborate across multiple teams
Excellent communication skills
Innovative and inquisitive nature
Agility to learn new tools and processes
Obtain/maintain a Veeva Associate Administrator Level certification

Responsibilities

Collaborate closely with the Veeva Drug Dev & Quality Cloud team to obtain high level overview knowledge of the Veeva vault platform and various vaults
Assist in the deployment of the Veeva Vault Platform and general releases including documentation and testing
System analysis, design, and configuration to meet business requirements
Contribute to all aspects of testing activities (unit, system, and/or user acceptance testing) of the vault release including script generation, execution, review, and approval
Deliver on validation documentation required on the various operational activities to ensure maintenance of the system’s validated state
Provide operational support activities of the Veeva vaults to global user community, such as maintenance and break-fix releases, security assessments, regulatory risk assessments, incident response, etc
Perform periodic user access review of the applications
Act as a functional mentor to more junior team members
Support platform updates, enhancements, end-user support, and access management activities including architecture, design, and testing

Skills

Veeva

Veeva Quality

Veeva Configuration

Vault

Architecture

Design

Testing

Access Management

Platform Updates

End-User Support

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free